Form 4 for CDNA CareDx, Inc.
Accepted 2024-09-16 00:00:00 ET · period of report 2024-09-12 · accession 0001543503-24-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-16 | 2024-09-12 | CDNA | Kennedy Keith | COO | A - Grant | $0.00 | +70.1K | 70.1K | New | $0 |
| D | 2024-09-16 | 2024-09-12 | CDNA | Kennedy Keith | COO | A - Grant | $0.00 | +100.7K | 100.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-12 | A | A | 70,101 | $0.00 | 70,101 | D | — | — | (F1) The reported securities are represented by restricted stock units, which will vest in four equal annual installments on the anniversary of the grant date until fully vested on September 12, 2028. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2024-09-12 | A | A | 100,651 | $0.00 | 100,651 | D | $29.43 · — to 2034-09-12 | 100,651 Common Stock | (F2) 1/4th of the shares subject to this option shall vest on September 12, 2025 and 1/48th of the shares subject to the option shall vest monthly thereafter through September 30, 2028. |